Aventura Private Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.6K Buy
307
+207
+207% +$28K 0.01% 351
2026
Q1
$12.8K Buy
+100
New +$12.5K ﹤0.01% 512

Other funds holding XBI

Aventura Private Wealth's XBI Position: Q2 2026 in Review

Aventura Private Wealth increased its State Street SPDR S&P Biotech ETF (XBI) stake by 207% in Q2 2026, buying an estimated $28K and bringing the position to 307 shares worth $48.6K. The position accounts for 0.01% of the portfolio, ranked #351.

Aventura Private Wealth first reported a position in XBI in Q1 2026 and has held it in 2 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Aventura Private Wealth held 307 shares of State Street SPDR S&P Biotech ETF worth $48.6K as of Q2 2026.
  • Aventura Private Wealth bought 207 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $28K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #351 holding.
  • Aventura Private Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q1 2026 and has held it in 2 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.